|

Home / Research / Publications / Targeted therapy to treat cervical cancer Alpelisib, Inavolisib, and Capivasertib, PI3-kinase and AKT inhibitors, suppress PIK3CA-mutated cervical cells and potentiate immunotherapy

Publications

Targeted therapy to treat cervical cancer Alpelisib, Inavolisib, and Capivasertib, PI3-kinase and AKT inhibitors, suppress PIK3CA-mutated cervical cells and potentiate immunotherapy

Introduction and Background

  • Cervical cancer is the 4th most common cancer in women.
  • The highest rates in incidence and mortality are in sub-Saharan Africa, Central America, Southeast Asia, and low-resource environments. However, over 4000 women in the US die of this cancer.
Download Publication
Learn More